1. Home
  2. ME

ME

23andMe Holding Co.

Logo 23andMe Holding Co.

Health Care

Precision Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment include Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Founded: 2006 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 214.0M IPO Year: N/A
Target Price: $3.88 AVG Volume (30 days): 6.7M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.11 EPS Growth: N/A
52 Week Low/High: $0.40 - $2.30 Next Earning Date: 05-23-2024
Revenue: $247,987,000 Revenue Growth: -19.40%
Revenue Growth (this year): -25.35% Revenue Growth (next year): 22.10%

Share on Social Networks: